Literature DB >> 6980230

Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia.

L M Nadler, J Ritz, M P Bates, E K Park, K C Anderson, S E Sallan, S F Schlossman.   

Abstract

Leukemic cells from 70% of patients with Ia+CALLA+ non-T cell acute lymphoblastic leukemia (ALL) express an antigen (B1) found on all normal B lymphocytes. In this study, ALL cells that do not express the B1 antigen were studied in an attempt to further elucidate the cellular lineage of these tumors. Non-T cell ALL lines and tumor cells isolated from patients with non-T cell ALL that are Ia + CALLA + B1- were studied in vitro with a variety of agents known to promote cellular differentiation. Phorbol diester (TPA) or phytohemagglutinin conditioned leukocyte culture media were capable of inducing the expression of B1 on all four non-T cell ALL lines tested. In contrast, B1 could not be induced under the identical conditions on a promyelocytic leukemia line or a T cell lymphoblastic leukemia line. With the induction of B1 on non-T cell ALL lines, cytoplasmic mu-heavy chain (c mu) became undetectable, whereas the expression of CALLA and Ia were unchanged. The expression of B1 was accompanied by a decrease of cellular proliferation and DNA synthesis, but not significant morphologic changes were noted. In addition, no other B or T cell antigens were detected. The cellular origin of non-T cell ALL was further investigated using tumor cells isolated from leukemic patients. Tumor cells from eight patients with Ia + CALLA + B1-c mu- ALL could be induced in vitro with TPA to express both B1 and c mu. In contrast, cells from five patients with Ia + CALLA-B1-c mu- non-T cell ALL could not be induced with TPA to express CALLA, B1 or c mu. These studies suggest that the non-T cell ALL are heterogeneous and represent a spectrum of early B cell differentiation including the pre- pre-B cell (Ia + CALLA + B1-c mu-), the intermediate pre-B cell (Ia + CALLA +B1 + c mu-), and finally the "true" pre-B cell (Ia + CALLA + B1 + c mu+). The cellular origin of the remaining Ia + CALLA-B1-c mu- form of non-T cell ALL (20%) is still unknown.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980230      PMCID: PMC371252          DOI: 10.1172/jci110633

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Antisera to acute lymphoblastic leukemia cells.

Authors:  M F Greaves; G Brown; N T Rapson; T A Lister
Journal:  Clin Immunol Immunopathol       Date:  1975-05

2.  Characterization of a unique cell line (LAZ 221) from human acute lymphocytic ("null" cell) leukemia.

Authors:  H Lazarus; E F Barell; A Krishan; D M Livingston; K Harris; S F Schlossman; L Chess
Journal:  Cancer Res       Date:  1978-05       Impact factor: 12.701

3.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

4.  B-cell neoplasia in man.

Authors:  S E Salmon; M Seligmann
Journal:  Lancet       Date:  1974-11-23       Impact factor: 79.321

5.  Studies of leukemic cell populations in culture.

Authors:  M T Aye; Y Niho; J E Till; E A McCulloch
Journal:  Blood       Date:  1974-08       Impact factor: 22.113

6.  Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia.

Authors:  L B Vogler; W M Crist; D E Bockman; E R Pearl; A R Lawton; M D Cooper
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

7.  A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens.

Authors:  J Minowada; T Tsubota; M F Greaves; T R Walters
Journal:  J Natl Cancer Inst       Date:  1977-07       Impact factor: 13.506

8.  Distribution of Ia-like molecules on the surface of normal and leukemic human cells.

Authors:  S F Schlossman; L Chess; R E Humphreys; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

9.  Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents.

Authors:  E Huberman; M F Callaham
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

10.  The occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias.

Authors:  S M Fu; R J Winchester; H G Kunkel
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

View more
  18 in total

1.  Cultured Reed-Sternberg cells HDLM-1 and KM-H2 can be induced to become histiocytelike cells. H-RS cells are not derived from lymphocytes.

Authors:  S M Hsu; S S Xie; P L Hsu
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

2.  Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes.

Authors:  T F Tedder; M Streuli; S F Schlossman; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

3.  Immunobiologic differences between normal and leukemic human B-cell precursors.

Authors:  F M Uckun; J A Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

4.  Monoclonal antibodies against differentiation antigens of lymphopoiesis.

Authors:  E Thiel
Journal:  Blut       Date:  1983-11

5.  In vitro enhancement of immunoglobulin gene expression in chronic lymphocytic leukemia.

Authors:  J Cossman; L M Neckers; R M Braziel; J B Trepel; S J Korsmeyer; A Bakhshi
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

6.  Construction of an antigenic map for human B-cell precursors.

Authors:  G B Melink; T W LeBien
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

7.  Immunoglobulin mu-chain gene rearrangement in a patient with T cell acute lymphoblastic leukemia.

Authors:  K Ha; M Minden; N Hozumi; E W Gelfand
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.

Authors:  R Foa; N Migone; M Saitta; M T Fierro; M C Giubellino; P Lusso; L Cordero di Montezemolo; R Miniero; F Lauria
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

9.  B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation.

Authors:  L M Nadler; S J Korsmeyer; K C Anderson; A W Boyd; B Slaughenhoupt; E Park; J Jensen; F Coral; R J Mayer; S E Sallan
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

10.  Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.

Authors:  F Caligaris-Cappio; L Bergui; L Tesio; G Pizzolo; F Malavasi; M Chilosi; D Campana; B van Camp; G Janossy
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.